← Back to headlines
Jefferies Highlights Iovance Biotherapeutics' Amtagvi Drug
Jefferies has drawn attention to Iovance Biotherapeutics Inc. and its Amtagvi drug, indicating potential interest or developments in the biopharmaceutical sector.
22 Apr, 11:25 — 22 Apr, 11:25
Sources
Showing 1 of 1 sources
Related Stories
Ebola Cases in DR Congo Surpass 6,000 as Outbreak Continues
28m ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
5h ago
Housing Crisis Surpasses Addiction as Top Reason for Irish Charity Support Requests
8h ago
Pakistan to Honor Nurse Who Rescued Sole Newborn From Hospital Fire
16h ago